This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Mead Johnson-Reckitt Move to Merge, Deal Closes on Jun 15
by Zacks Equity Research
Mead Johnson Nutrition Company (MJN) and Reckitt Benckiser have cleared the final regulatory hurdle of their impending merger.
Mead Johnson (MJN) Lags Q1 Earnings, Awaits Merger Closure
by Zacks Equity Research
Mead Johnson Nutrition Company (MJN) reported first-quarter 2017 adjusted earnings per share (EPS) of 80 cents at constant exchange rate or CER, down 8% year over year.
Mead Johnson (MJN) Misses Q1 Earnings and Sales Estimates
by Zacks Equity Research
Currently, Mead Johnson has a Zacks Rank #3 (Hold) but that could change following its first-quarter 2017 earnings report which has just released.
Can Mead Johnson (MJN) Spring a Surprise in Q1 Earnings?
by Zacks Equity Research
Mead Johnson Nutrition Company (MJN) is expected to report first-quarter 2017 results on Apr 27, before the opening bell.
Mead Johnson Acquires Bega's Strategic Capabilities Business
by Zacks Equity Research
Mead Johnson Nutrition Company (MJN) recently inked an agreement with Bega Cheese Limited to acquire the latter's spray drying and finishing capabilities business in Australia.
Why Is Mead Johnson (MJN) Up 20.3% Since the Last Earnings Report?
by Zacks Equity Research
Mead Johnson (MJN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mead Johnson-Reckitt Benckiser Mega Deal: A Strategic Fit?
by Zacks Equity Research
Pediatric nutrition manufacturer Mead Johnson Nutrition Company (MJN) recently announced an agreement to be acquired by British consumer-products maker, Reckitt Benckiser Group plc.
New Strong Sell Stocks for January 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
Mead Johnson (MJN) Misses Q4 Earnings, Sales; Guides '17
by Zacks Equity Research
Mead Johnson (MJN) reported fourth-quarter 2016 adjusted EPS of 78 cents, missing the Zacks Consensus Estimate of 83 cents by 6%.
Mead Johnson (MJN): Misses Q4 Earnings and Sales Estimates
by Zacks Equity Research
Mead Johnson (MJN) has missed the Zacks Consensus Estimate in terms of both Earnings and Sales.
Mead Johnson (MJN) Q4 Earnings: Disappointment in Store?
by Zacks Equity Research
Mead Johnson Nutrition Company (MJN) is scheduled to report fourth-quarter 2016 results on Jan 26, before the opening bell.
Amkor Tech, Mead Johnson Nutrition, Ambarella, Applied Optoelectronics and Cirrus Logic highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Amkor Tech, Mead Johnson Nutrition, Ambarella, Applied Optoelectronics and Cirrus Logic highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Mead Johnson Nutrition (MJN)
by Eric Dutram
It is time to grow up and admit that staples stocks like this one are in for some trouble thanks to rising rates.
Stock Market News for September 08, 2016
by Zacks Equity Research
Bear of the Day: Mead Johnson (MJN)
by Jeremy Mullin
Any benefit that this pediatric nutrition company might reap from China recently lifting its "one child policy" already appears to be priced in.